Mobic — Class III drug recall D-0007-2018
Terminated recall by Boehringer Ingelheim Pharmaceuticals, Inc., reported 2017-10-18, distributed in CO, OH. Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
| Recall number | D-0007-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Boehringer Ingelheim Pharmaceuticals, Inc., Danbury, CT, United States |
| Recall initiated | 2017-09-22 |
| Classified | 2017-10-06 |
| Reported by FDA | 2017-10-18 |
| Terminated | 2018-04-18 |
| Distributed | CO, OH |
| Quantity | 128 bottles |
| Reason classes | labeling |
| NDC | 00597-0030-01 |
| Lot numbers | 754037 |
Product
Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01
Reason for recall
Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0007-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.